Prognostic impact of low-shear whole blood viscosity in hypertensive men

European Journal of Clinical Investigation

Volumn 35, Issue 2, 2005, Pages 93-98

  Ciuffetti, Giovanni ^a   Schillaci, G ^a   Lombardini, R ^a   Pirro, M ^a   Vaudo, G ^a   Mannarino, E ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Blood viscosity; Cardiovascular disease; Hypertension; Low shear rate; Men; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD VISCOSITY; BODY MASS; CARDIOVASCULAR RISK; ESSENTIAL HYPERTENSION; HEART RATE; HEMATOCRIT; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SHEAR RATE; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADULT; ANGINA, UNSTABLE; BLOOD VISCOSITY; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS;

EID: 13544258628     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01437.x     Document Type: Article

References (26)

1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
2. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension. A new target for treatment? Circulation 2001;104:735-40.
3. Ciuffetti G, Schillaci G, Innocente S, Lombardini R, Pasqualini L, Notaristefano S et al. Capillary rarefaction and abnormal cardiovascular reactivity in hypertension. J Hypertens 2003;21:2297-303.
4. Lowe GDO. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis and vascular medicine. Ann Periodontol 1998;3:121-5.
5. Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000;21:515-20.
6. Koenig W, Sund M, Filipiak B, Doring A, Lowel H, Ernst E. Plasma viscosity and the risk of coronary heart disease. Results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscl Thromb Vasc Biol 1998;18:768-72.
7. Lowe GDO. Blood rheology and vascular disease. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and Thrombosis, 3rd edn. Edinburgh, UK: Churchill Livingstone; 1994.pp.1169-88.
8. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997;96:168-73.
9. Sweetnam PM, Thomas HF, Yarnell JW, Beswick AD, Baker IA, Elwood PC. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease, the Caerphilly and Speedwell studies. Eur Heart J 1996;17:1814-20.
10. Chabanel A, Chien S. Blood viscosity as a factor in human hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd edn. New York, NY: USA. Raven Press, Ltd; 1995.pp.365-76.
11. Matrai A, Whittington RB, Ernst E. A sample method of estimating whole blood viscosity at standardized haematocrit. Clin Haemorheol 1987;7:261-5.
12. Cox DR. Regression models and life-tables. J Roy Stat Soc B 1972;34:187-220.
13. Collett D. Modeling Survival Data in Medical Research. London, UK: Chapman & Hall; 1994.pp.72-85.
14. Devereux RB, Drayer JIM, Chien S, Pickering TG, Letcher RL, DeYoung JL et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 1984;54:592-5.
15. Leschke M, Motz W, Blanke H, Strauer BE. Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension. J Cardiovasc Pharmacol 1987;10[Suppl. 6]S103-S10.
16. Simon AC, Levenson J, Flaud P. Pulsatile flow and oscillating wall shear stresses in the brachial artery of normotensive and hypertensive subjects. Cardiovasc Res 1990;24:129-36.
17. Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen and concentration. Am J Med 1981;70:1195-202.
18. Levenson J, Simon AC, Cambien A, Beretti C. Cigarette smoking and hypertension. Factors independently associated with blood viscosity and arterial rigidity. Arteriosclerosis 1987;7:572-7.
19. + co-transport and the hemodynamics of hypertension. Hypertension 1987;9:459-66.
20. 2+ content (total and cytosolic) and erythrocyte membrane fluidity in several clinical conditions. Clin Hemorheol 1993;13:227-35.
21. 2+ concentration in essential hypertension. Hypertension 1992;19:167-74.
22. Goldstone J, Schmid-Schönbein H, Wells R. The rheology of red blood cell aggregates. Microvasc Res 1970;2:273-86.
23. Chien S, Sung LA, Simchon S, Lee MM, Jan KM, Skalak R. Energy balance if red cell interactions. Ann N Y Acad Sci 1983;416:190-206.
24. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S et al. High C-reactive protein levels in never-treated hypertension: the role of systolic and pulse pressure. J Hypertens 2003;21:2297-303.
25. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
26. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003;108:2993-9.